Target intelligence / Profile preview

Zinc finger protein 347 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Zinc finger protein 347 pseudogene (ENSG00000277509) is a non-functional, non-protein-coding segment of the human genome related to the gene for zinc finger protein 347. As a pseudogene, it does not produce an active protein and therefore has no direct biological activity, no known disease associations, and is not a therapeutic target. Its presence in the genome may provide evolutionary or regulatory context, but no specific biological or pharmacological functions are currently attributed to it.

Other names
ZNF347PZinc finger protein 347 pseudogene

Beyond the preview

Go deeper on Zinc finger protein 347 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 347 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call